AMENDMENT No. 1 to Clinical Study Agreement for the study entitled "Clinical Research in Patients affected by Parkinson’s Disease Using Direct Delivery of the GAD Genes in the Brain", under the direction of Dr. Michael G. Kaplitt, Principal InvestigatorClinical Study Agreement • September 30th, 2004 • Neurologix Inc/De • Pharmaceutical preparations
Contract Type FiledSeptember 30th, 2004 Company IndustryTHIS AMENDMENT TO THE CLINICAL STUDY AGREEMENT ("Amendment") is by and between Cornell University for its Medical College ("the Medical College") and Neurologix, Inc. ("Sponsor").